Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
about
K-ras mutational status in cytohistological tissue as a molecular marker for the diagnosis of pancreatic cancer: a systematic review and meta-analysisStrategies for early detection of resectable pancreatic cancerHuman papillomavirus DNA in plasma of patients with cervical cancerLiquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acidsCell-free circulating tumor DNA in cancerPotential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell CarcinomaCirculating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic CancerBlood-based analyses of cancer: circulating tumor cells and circulating tumor DNAPancreatic cancer.Circulating Tumor DNA as Biomarkers for Cancer Detection.Cellular and molecular phenotypes of proliferating stromal cells from human carcinomasA prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer.Prognostic significance of K-ras mutations in pancreatic cancer: a meta-analysisIdentifying molecular markers for the early detection of pancreatic neoplasia.Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNAPrognostic molecular biomarkers for cutaneous malignant melanomaPhase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.Specific mutations of hepatitis B virus in plasma predict liver cancer development.Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Diagnostic and prognostic biomarkers in pancreatic carcinoma.Metabolism addiction in pancreatic cancer.Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.KRAS mutations in blood circulating cell-free DNA: a pancreatic cancer case-controlCirculating and stool nucleic acid analysis for colorectal cancer diagnosis.Selective 'stencil'-aided pre-PCR cleavage of wild-type sequences as a novel approach to detection of mutant K-RAS.Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.Plasma DNA restoration for PCR applications.Ultrasensitive plasma ctDNA KRAS assay for detection, prognosis, and assessment of therapeutic response in patients with unresectable pancreatic ductal adenocarcinoma.A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up.The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
P2860
Q21284688-AEF6115F-7114-4FA1-B54E-86261C4AADB0Q24564006-08E6C3E6-61E9-4FFC-ADE6-779921BCFD75Q24798417-B6C87EB2-B738-489A-B0DA-7B5C11340F73Q26739062-4225916D-517E-41C5-BFAC-F9837F684177Q26750899-FDA71D6C-A815-4844-9D76-319CF3EDF79DQ26777900-1971A453-E0C5-4E57-A515-7B60B841C5E1Q28073765-FACA96F1-9CCB-4D49-A0F1-329AC0363E3CQ28239638-51CE6A30-A0EC-4184-BC66-A61F5E216132Q30490247-6A4A554B-FC66-49FB-8A28-BE6BBD766CFDQ33632125-82BF60E7-BA2E-422B-A27B-A01467F7EE2FQ33847830-47D2A0A7-0EF4-466F-96E7-8C79DD456EF8Q35595377-7650CEA3-F1DB-4792-87BD-8BAC347D9D39Q35668940-20B1B202-B453-43CE-AB6F-ECB7EFBAF4D8Q35828060-7CE361E8-37C5-4EEA-BB6D-9E42626B5FC5Q36018926-4CEB04C6-F570-45A4-81CF-CF3DE06DE3E2Q36328508-6FC21C8B-14D4-4185-B3A2-23D6D322B739Q36646098-DE0A9AA1-CBA9-4863-91DF-BE0894DBE3D9Q36905877-63C9D89F-133A-4451-9179-28DC83B2A2ECQ37068863-DEE070B4-CF4E-44AC-AF9F-661F0962B057Q37074286-37D527C7-B9A0-4A48-B378-C4B612F06523Q37242412-37B3EE9F-C6E6-4437-B4B7-89C134CBC0E1Q37284685-3366ACEA-D63E-4130-9168-D393234E22DFQ37620679-D11ACF12-0160-4F8F-B5CE-8ED6F9162018Q37639092-F4D42709-30B0-4221-AE4D-3DC9E0A8323FQ37694710-9D892E07-8C72-468C-A43C-2628DF155C17Q38191574-26B0851D-6AE4-4D4B-B2D0-13E1FEA28F70Q38297427-3D755EEA-9685-4D81-949A-0D555C9CC2D1Q38726457-11A30935-0F1C-4718-AB89-D0FD3AF26D2FQ41347759-3C8136EF-3D58-41B9-B12A-3B2EF8B90C4CQ41385360-B63B6BF5-7D5E-4FC0-A58E-BF1DD9EB0D8FQ46736806-BB3F7A98-5884-4828-844E-D9FF70A90871Q46968191-E9C35D01-1C3C-44E8-A963-A6AE3D4AD311Q57175806-CB2D6D4F-0F16-4C6C-81B3-313E4FE0EA65
P2860
Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Detection of K-ras gene mutati ...... clinicopathological features.
@en
Detection of K-ras gene mutati ...... clinicopathological features.
@nl
type
label
Detection of K-ras gene mutati ...... clinicopathological features.
@en
Detection of K-ras gene mutati ...... clinicopathological features.
@nl
prefLabel
Detection of K-ras gene mutati ...... clinicopathological features.
@en
Detection of K-ras gene mutati ...... clinicopathological features.
@nl
P2093
P1476
Detection of K-ras gene mutati ...... h clinicopathological features
@en
P2093
Fujiwara Y
Nakamori S
Nishisho I
P304
P407
P577
1998-06-01T00:00:00Z